Litigation Details for Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)
✉ Email this page to a colleague
Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-09-03 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Mitchell S. Goldberg |
| Jury Demand | None | Referred To | |
| Patents | 7,741,358; 8,022,228 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Forest Laboratories LLC v. Sigmapharm Laboratories LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Forest Laboratories LLC v. Sigmapharm Laboratories LLC (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-11-16 | 409 | assignee of U.S. Patent Nos. 5,763,476 (“the ’476 patent”), 7,741,358 (“the ’358 patent”), and 8,022,228…all three patents covering Saphris®—i.e., the ’476 patent, the ’358 patent, and the ’228 patent. (D.I. …infringement of two of the three patents covering Saphris®—the ’476 patent and ’358 patent. (D.I. 1, C.A. No.…counterclaims seeking a declaration that the ’358 patent and ’228 patent were invalid. (Id.). As a result, the …and 10 of the ’476 patent. (Id.). Finally, Judge Robinson held that the ’476 patent was valid and entered | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
